pancreas and glp 1 Understanding GLP-1 receptor agonists their impact on drug discovery GLP-1 | Pancreapedia
Description
Fiber breakdown: Gut bacteria break down fiber into short-chain fatty acids (SCFAs)
GLP-2 (Tirzepatide) is a dual incretin receptor agonist widely utilized in preclinical research involving metabolic regulation, incretin signaling, and energy balance-associated biochemical pathways
The results of cardiovascular and kidney outcomes trials involving sodiumglucose cotransporter-2 inhibitors and glucagon-like peptide-1 receptor agonists, including assessment of subgroups, inform broader recommendations for cardiorenal protection in people with diabetes at high risk of cardiorenal disease
Company is seeking to capitalize on the rising usage of GLP-1 medications.
Clinical Interpretation For the vast majority of patients, GLP1 RAs remain safe from a pancreatitis perspective
